Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,145 | -43,155 | -21,825 | -105,624 | -149,631 |
| Depreciation Amortization | 325 | 214 | 104 | 992 | 912 |
| Accounts payable and accrued liabilities | 293 | 428 | 435 | 2,691 | 1,095 |
| Other Working Capital | -8,115 | -5,082 | -5,298 | 2,078 | -3,322 |
| Other Operating Activity | 2,264 | -1,382 | -2,052 | 15,558 | 86,110 |
| Operating Cash Flow | $-67,378 | $-48,977 | $-28,636 | $-84,305 | $-64,836 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19 | N/A | N/A | 114,116 | 114,116 |
| Other Financing Activity | -94 | 0 | 0 | -311 | -311 |
| Financing Cash Flow | $-75 | $N/A | $N/A | $113,805 | $113,805 |
| Beginning Cash Position | 79,398 | 79,398 | 79,398 | 49,898 | 49,898 |
| End Cash Position | 11,945 | 30,421 | 50,762 | 79,398 | 98,867 |
| Net Cash Flow | $-67,453 | $-48,977 | $-28,636 | $29,500 | $48,969 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,378 | -48,977 | -28,636 | -84,305 | -64,836 |
| Free Cash Flow | -67,378 | -48,977 | -28,636 | -84,305 | -64,836 |